FINAL - Derm Flashcards
Describe the epidemiology of rosacea.
-usually 30- 50 years (can occur in children)
-genetic factors (celtic, northern european), more common in fair skin
-F>M
What is the pathophysiology of rosacea?
Cause unknown- involves genetic factors, skin sensitivity, and triggers.
-Innate immunity activated
-Vascular hyperactivity
-Inflammation
Triggers for rosacea?
Hot food and drinks, spicy food, red wine, alcohol, sunlight, harsh skin care
Time course of rosacea?
Chronic and fluctuating condition
Describe the signs and symptoms of rosacea.
-Characterized by redness, telangiectasia, flushing, blushing (vascular component), and inflammatory papules and pustules
-Central facial erythema (centrofacial distribution- forehead, cheeks, nose, around the eyes)
-No comedones
What are some ocular manifestations of rosacea?
-blepharitis and conjunctivitis
-gritty, burning, itchy eyes
-lacrimation
What is rhinophyma?
-Bulbous nose due to chronic inflammation
-Irreversible skin thickening
-More common in M
How to diagnose rosacea? Ddx?
Clinical diagnosis
-Presence of 1+ of primary features: flushing, erythema, papules and pustules, telangiectasia
-May include 1+ secondary feature: burning or stinging, dry appearance, edema, phymatous changes, ocular manifestations, peripheral location.
Ddx- acne vulgaris, seborrheic dermatitis, perioral dermatitis, contact dermatitis
Non pharm management of rosacea?
-Avoid triggers (hot food and drinks, spicy food, red wine, sunlight)
-Wear sunscreen
-Green based cosmetics can mask redness
-Avoid harsh skincare
-Photodynamic therapy
T/F Corticosteroids are first line for rosacea
FALSE avoid corticosteroids
Pharm management of rosacea?
Tx usually only if pustules
-Topical (metronidazole) or systemic (tetracycline, erythromycin)
-If chronic and relapsing, referal to derm for oral isotretinoin
Describe epidemiology and risk factors for acne vulgaris.
-85% of adolescents and young adults (9- 24 years; peak prevalence/ severity during puberty)
* Preteens: comdeonal lesions
* Teenage: inflammatory lesions
-Most common skin conditions seen by health care providers in Canada
-Risk factors: genetic predisposition, white> black/ Hispanic/ Asian, excessive face washing, local skin occlusion, conditions with hormonal imbalance, medications (lithium, phenytoin, steroids, androgens, etc.), oily cosmetics, ointments, emotional stress, local occlusion of pores
What are endogenous (internal/ host factors) that contribute to acne?
- Hormones (androgen excess, changes in estrogen/ progesterone during menses, stressed induced cortisol release)
- Skin microflora balance
- Sebum overproduction
- Skin hyperkeratinization
- Pro-inflammatory pathways
What are exogenous (extenal) factors that can contribute to acne?
- Medications/ drugs (progestin only contraceptives, isoniazid, phenytoin, steroids, lithium)
- Chemical (ptrolium)
- Oily/ waxy hair products and cosmetics
- Over zelous facial cleansing
- Local skin occlusion from sports gear
- Excessive perspiration
- Diet (high glycemic index, high dairy intake)
Briefly describe patho of acne vulgaris
-Hyperkeratinization leads to pilosebaceous follicle plugging, comedone formation
-Sebum over production leads to over proliferaction of c. acnes
-This leads to inflammation and immune response
When does acne vulgaris tend to resolve
By third decade after birth
Signs and symptoms of acne vulgaris?
-Acne lesions primarily affect the face (central facial areas, T zone (forehead, nose, chin), as well as areas of body dense in sebaceous glands (neck, chest, shoulders, back)
-Comedones
* Open (black heads- small, dome shaped, open orifice containing dark central material (oxidized fatty acids, not dirt)
* Closed (white heads- small, flesh colored, no surrounding erythema (plugged sebaceous follicle)
-Inflammatory lesions
* Pustules (superficial epidermal layer)
* Papules (lower dermal layer/ deeper- more severe inflammatory reaction, scarring may result)
* Nodules or cyst (supperative inflammatory lesions located in deep dermis; assoc with most severe form of acne.
Is acne in pre- pubescent kids abnormal?
If >1, yes! Concern for precocious puberty, hormone secreting tumours
Describe/ differentiate mild, moderate, and severe acne.
Mild- comedones, few papules/ pustules, no scarring
Moderate- comedones, papules and pustules (may or may not have scarring)
Severe- Nodules, cysts, severe scarring
Non pharm recommendations for acne vulgaris?
Avoid excess skin care, avoid stress ,avoid scrubs/ toners, use oil free make up, dont touch/ squeeze/ pick, wash face once daily (no more than BID) with water and soap less cleanser, avoid sunlight, use non comodegenic moisturizers, evidence limited for diet.
Describe step up therapy for acne
1) General measures
2) Topical BPO, topical retinoids
3) Add topical antibiotics (if papulopustular/ inflammatory)
4) Step up options include oral antibiotics, combined OCP
5) Isotretinoin (systemic)
Can your patient use BPO and topical retinoids in addition to isotretinoin?
Avoid, increased drying effect
What topical antibiotics are used for mild- mod acne?
o Clindamycin
o Erythromycin
o Dapsone
What oral antibiotics are used for moderate acne? Describe common AE
o Tetracycline and derivatives are first line (CI <8, active pregnancy, DI isotretinoin)
o Azithromycin, TMP-SMX, amoxicillin, cephalexin generally less effective.
o AE: candida infection, GI upset, photosensitivity
T/F IUDs are good for acne
F- at least for hormonal- unopposed progestin leads to acne, hirsutism
Describe teaching and monitoring for accutane.
- Influences all aspects of acne formation.
- Strongest and most effective acne tx, can provide long term remission
- First line for severe (nodulocystic) acne
- Many side effects and potential AE
o Skin dryness, GI upset, myalgia and joint pain, fatigue, HA, hematuria, hematologic abnormalities, elevated triglycerides
o VERY teratogenic*** 2 negative preg tests separated by 1 month, 2 forms active birth control. Unsafe in lactation
o Baseline CBC, LFTs, lipid panel and ongoing monitoring (i.e., Toronto Notes suggests q1-2 weeks until lipid/ LFT response is stabilized)
What is psoriasis?
-Chronic inflammatory skin condition
-Comes in many types- plaque, guttate, pustular, erythrodermic, inverse
Describe epidemiology and risk factors of plaque psoriasis
1.5-2% of people
M=F
Peak of onset: bimodal (20-30, 50-60)
Polygenic inheritance- 8% with one affected parent, 41% with both parents affected
Risk factors: smoking, obesity, alcohol, drugs, infections, physical trauma (Koebner phenomenon- appearance of new lesions on skin secondary to trauma)
Describe patho pf psoriasis
Not fully understood, genetic and immunologic factors.
* Skin infiltrated by activated T cells, which stimulate proliferation of keratinocytes. Dysregulated keratinocyte turnover leads to formation of thick plaques.
* Epidermal hyperplasia; epidermal cells fail to secrete lipids which results in flaky and scaly skin
Clinical course of psoriasis?
Chronic, unpredictable, multi-system, many comorbidities (i.e., arthritis, ocular), often poor QOL (depression),
Guttate has best prognosis.
How is psoriasis diagnosed?
Clinical diagnosis
Biopsy if abnormal
Genetic testing not used
(Up To DatE)
Ddx for psoriasis?
Atopic dermatitis, mycosis fungoides, cutaneous T cell lymphoma, seborrheic dermatitis, tinea, nummular dermatitis, lichen planus
Describe the classic clinical presentation of plaque psoriasis
-Well circumscribed, sharply defined
-Erythematous papules/ plaques
-Silvery white coarse scales
-Auspitz sign (pinpoint bleeding when scale removed)
-Common sites include scalp, EXTENSOR surfaces (elbows, knees), trunk (esp. buttocks, gluteal cleft), nails, pressure areas (recall- koebner phenomenon- lesions form at site of trauma)
Treatment for mild plaque psoriasis?
Mild= <3% of body surface area
-Topical steroids +/- topical vitamin D analogue
-Emollients
-Possible phototherapy
Treatment for moderate to severe plaque psoriasis (3-10% of body surface area; >10% BSA )
-Phototherapy
-Systemic or biologic therapy depending on patient hx/ comorbidities methotrexate, biologic immune modifying agents, cyclosporine)
-Topical steroids, topical vit D3
What is guttate psoriasis?
Discrete, scattered salmon-pink small scaling papules (<1cm)
-Rain drop shaped
-Sites: diffuse, usually on trunk and legs, sparing palms and soles
-Often occurs before/ after streptococcal pharyngitis
Treatment for guttate psoriasis?
UVB phototherapy, sunlight, lubricants, topical steroids
Describe the clinical presentation of pustular psoriasis
Sudden onset of diffuse erythematous macules and papules which evolve rapidly into pustules, can be painful. These can desquamate.
-lesions are non- infectious
-May be generalized or localized
-Patient usually has a history of psoriasis; may occur with sudden withdrawal from steroid therapy
-Patient appears toxic
T/F pustular psoriasis can be life threatening
True
Treatment for pustular psoriasis?
Methotrexate, cyclosporine, acitretin, UV, biologics
Describe the clinical presentation for erythrodermic psoriasis.
Generalized erythema (>90% of BSA) with fine desquamative scale on surface
-Associated signs and symptoms: arthralgia, swelling, pruritus, pain, dehydration, electrolyte imbalance
-Aggravating factors: lithium, β-blockers, NSAIDs, antimalarials, phototoxic reaction, infection
-Increased risk infection
Treatment for erythrodermic psoriasis?
-Potentially life-threatening, requires immediate medical care
-IV fuids, monitor fuids and electrolytes, may require hospitalization
-Treat underlying aggravating condition, sun avoidance
-Cyclosporine, acitretin, methotrexate, UV, biologics
Describe the clinical presentation of inverse psoriasis.
Erythematous plaques on flexural surfaces such as axillae, inframammary folds, gluteal fold, inguinal folds (affects intertriginous areas)
-Lesions may be macerated
Treatment for inverse psoriasis?
-Low potency topical corticosteroids
-Topical vitamin D analogues (e.g. calcipotriene, calcitriol)
-Topical calcineurin inhibitors (e.g. tacrolimus, pimecrolimus)
What percentage of patients with psoriasis also suffer from psoriatic arthritis?
20-30%
T/ F Psoriatic patients with nail or scalp involvement are at a higher risk for developing psoriatic arthritis
True
How does psoriatic arthritis present?
Different patterns- can affect DIPS, be symmetrical or asymmetrical, destructive, or cause sacroillitis and spondylitis
-Peripheral arthritis, axial disease, enthesitis (inflammation at insertion of tendons/ ligaments, i.e., achilles, plantar fascia), dactylitis (diffuse sausage swelling of digit), skin and nail (pitting, splinter emorrages) disease
-Non specific lab findings
Treatment of psoriatic arthritis?
-Imaging (XR)
-NSAIDs
-Local glucocorticoid injection into entheses can be beneficial, but has not been systematically evaluated (do not inject achilles- associated with rupture)
-Referral to rheumatology (possible TNF, interleukin, or other agents, DMARDs, methotrexate)
-Surgery for severe destruction
Why do we use emollients in psoriasis?
Increase barrier function, hydration; reduce fissure formation
Tar is a possible treatment option for psoriasis. Why?
inhibits DNA synthesis, increases cell turnover
however, has poor long term compliance
What is the function of topical corticosteroids in psoriasis?
Reduce scaling, redness, and thickness; use appropriate potency steroid based on area and severity of psoriasis